← Browse by Condition
Medical Condition
biomarkers
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT05713851 Phase 2, Phase 3
Recruiting
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
Enrollment
100 pts
Location
Mexico
Sponsor
Instituto Nacional de Ciencias...
NCT07171151
Recruiting
Detection of Disease Marker Factors in Cyst Fluid
Enrollment
25 pts
Location
Turkey (Türkiye)
Sponsor
Harran University